Japanese flag Korean flag Simple Chinese flag Traditional Chinese flag  

Overview
Register 
PDF Download 
Conference-at-a-Glance
Posters 
Hotel & Travel 
Sponsor & Exhibit
Press Pass 
Request Brochure 

 

Bio-itworld

Expert Review of Vaccines

Expert Review of Anticancer Therapy

http://chidb.com/logos/SCIENCE_AAAS.jpg

GE Healthcare

Decision Biomarkers


Novel Vaccines

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

 
Vac Header 
 
Overview  |  Day 1  |  Day 2  |  Day 3  |  Novel Vaccines Brochure 

Ashley J. BirkettAshley J. Birkett, Ph.D., Director, Preclinical Research & Development, The PATH Malaria Vaccine Initiative

 

konstantim ChumakovKonstantin Chumakov, Ph.D., Chief, Laboratory of Method Development, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA)

 

 

 

Heather DavisHeather Davis, Ph.D., Senior Vice President, Vaccines Research Site Head, Ottawa Research Laboratories, Coley Pharmaceutical Group, a Pfizer company

 

 

 

Ofer LevyOfer Levy, M.D., Ph.D., Staff Physician, Infectious Diseases and Principal Investigator, Harvard Medical School/Children’s Hospital Boston


 




Jan Vinje Jan Vinjé, Ph.D., Head, National Calicivirus Laboratory, Gastroenteritis & Respiratory Viruses Laboratory Branch, Division of Viral Diseases (DVD), National Center for Immunizations and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC)

 

 

 


Nicholas I. ObiriNicholas I. Obiri, Ph.D., Senior Regulatory
Affairs Specialist, Office of Regulatory Affairs, National Institute of Allergy and Infectious Diseases (NIAID), NIH

 

 

Scientific Advisors
Carol Belzer, Ph.D., Microbiology, Biotechnology
Immunology & Diagnostics, US Dept of Agriculture
William Egan, Ph.D., Executive Director, PharmaNet Consulting
Michael Dekleva, Ph.D., Director, Worldwide Regulatory Group Vaccines, Merck & Co
Gregory M. Glenn, M.D., Chief Scientific Officer, IOMAI Corporation
Jamie K. Scott, Ph.D., Professor & Canada Research Chair in Molecular Immunity, Molecular Biology & Biochemistry, Simon Fraser UniversityMichael Dekleva, Ph.D., Director, Worldwide Regulatory Group Vaccines, Merck & Co

Overview  |  Day 1  |  Day 2  |  Day 3  |  Novel Vaccines Brochure 


http://chidb.com/2007/imt/NathalieGarcon3.jpgSelected Papers:
A
djuvants: Breathing New Life Into Vaccines

An interview with Nathalie Garcon, Pharm.D., Ph.D., Vice President,
Research and North America R&D,  Guano SmithKline Biologicals, 
by Malorye Allison, contributing editor, PharmaWeek
 

 

 

A Novel Strategy to Mimic Discontinuous Protective Epitopes Using a Synthetic Scaffold
Robert Liskamp, Ph.D., Professor, Pharmaceutical Sciences and Chemistry, Utrecht University

To post questions to any of the authors, or to submit a paper or comment, please email:  vaccines@healthtech.com


By Series:
By Region: